Analyzing multiple mammograms improves breast cancer risk prediction

A new method of analyzing mammograms identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did. The new method, powered by artificial intelligence, could help diagnose cancer earlier and guide recommendations for earlier screening, additional imaging or risk-reducing medications.

from Women's Health News -- ScienceDaily https://ift.tt/J38p7qN

Analyzing multiple mammograms improves breast cancer risk prediction

A new method of analyzing mammograms identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did. The new method, powered by artificial intelligence, could help diagnose cancer earlier and guide recommendations for earlier screening, additional imaging or risk-reducing medications.

from Breast Cancer News -- ScienceDaily https://ift.tt/J38p7qN

How breast cancer cells survive in bone marrow after remission

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

from Breast Cancer News -- ScienceDaily https://ift.tt/4Tvrjt3

How breast cancer cells survive in bone marrow after remission

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

from Women's Health News -- ScienceDaily https://ift.tt/4Tvrjt3

Long-term benefit from anti-hormonal treatment is influenced by menopausal status

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.

from Women's Health News -- ScienceDaily https://ift.tt/Bjg1weo

Long-term benefit from anti-hormonal treatment is influenced by menopausal status

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.

from Breast Cancer News -- ScienceDaily https://ift.tt/Bjg1weo

Scientists identify brain cell type as master controller of urination

Researchers have identified a subset of brain cells in mice that act as the master regulators of urination.

from Women's Health News -- ScienceDaily https://ift.tt/8sPVeqK

Different menopausal hormone treatments pose different risks

Researchers have analysed the effects of seven different hormone treatments for menopausal symptoms on the risk of blood clots, stroke and heart attack. The study, which involved around one million women aged between 50 and 58, is the largest and most comprehensive study of currently prescribed hormonal substances in the world. The results show that the risks differ depending on the active substance and how the medicine is taken.

from Women's Health News -- ScienceDaily https://ift.tt/p1Pk450

Cervical cancer deaths in young women plummet after introduction of HPV vaccine

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.

from Women's Health News -- ScienceDaily https://ift.tt/f7Y4DOo

Scientists find why tamoxifen works better for some people

Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.

from Breast Cancer News -- ScienceDaily https://ift.tt/gdwG1XI